Exploring 5-nitrofuran derivatives against nosocomial pathogens: Synthesis, antimicrobial activity and chemometric analysis-Reference-Cited by-同舟云学术

Exploring 5-nitrofuran derivatives against nosocomial pathogens: Synthesis, antimicrobial activity and chemometric analysis

Published:2014-05 Issue:10 Volume:22 Page:2844-2854
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Zorzi Rodrigo Rocha,Jorge Salomão Dória,Palace-Berl Fanny,Pasqualoto Kerly Fernanda Mesquita,Bortolozzo Leandro de Sá,de Castro Siqueira André Murillo,Tavares Leoberto Costa

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference72 articles.

1. World Health Organization, Prevention of hospital-acquired infections 2002, (accessed 2011).

2. Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002

3. European Centre for Disease Prevention and Control, Healthcare-associated infections 2013, (accessed March 19 2013).

4. Inadequate Antimicrobial Treatment: An Important Determinant of Outcome for Hospitalized Patients

5. Development of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus aureus

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Periphery Design Allows Control of the New Nitrofurans Antimicrobial Selectivity;Molecules;2024-07-17

2. The Nitrofuran-Warhead-Equipped Spirocyclic Azetidines Show Excellent Activity against Mycobacterium tuberculosis;Molecules;2024-06-27

3. Nitrofuran-3-carboxylates: synthesis and structure;Mendeleev Communications;2024-05

4. Novel 5-Nitrofuran-Tagged Imidazo-Fused Azines and Azoles Amenable by the Groebke–Blackburn–Bienaymé Multicomponent Reaction: Activity Profile against ESKAPE Pathogens and Mycobacteria;Biomedicines;2022-09-06

5. Hetaryl- and heteroarylvinyl-substituted nitrofurans identified as non-cytotoxic selective antitubercular agents;Mendeleev Communications;2022-07